Elvisfan schreef op 5 juli 2019 12:19:
[...]
inderdaad Dagobert, de belgen staan al verder :)) wat nu?
www.celyad.com/en/news/celyad-present...No clinical evidence of Graft-versus-Host Disease (GvHD) have been observed. These initial data support the ability of the company’s novel inhibitory peptide TIM (T cell receptor (TCR) Inhibiting Molecule to reduce signaling of the TCR complex
Host-versus-Graft (HvG) response against the allogeneic CYAD-101 cells appears to be controlled as evidenced by similar levels of CYAD-101 cell engraftment following the second and third infusions of the allogeneic cell therapy